Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?

Autogenous bone grafts from the iliac crest have long been the gold standard for repair and reconstruction of bone; however harvesting of the grafts from the iliac crest is associated with donor site morbidity, particularly chronic pain. The bone morphogenetic proteins (BMPs) are soluble bone matrix glycoproteins that induce the differentiation of osteoprogenitor cells into osteogenic cells and have the potential to act as autogenous bone graft substitutes. BMP-2, which can be produced with recombinant technology, is highly osteoinductive, inducing bone formation by stimulating the differentiation of mesenchymal cells into chrondroblasts and osteoblasts. At present, more than 1,000 patients have received rhBMP-2 in clinical trials for acute open tibial fracture and interbody fusion procedures for the treatment of degenerative disc disease. Data suggest that rhBMP-2 therapy may offer an effective alternative to autogenous bone graft for recalcitrant bone unions and spinal fusion, obviating donor site morbidity.

[1]  V. Rosen,et al.  Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.

[2]  A. Felstead,et al.  Training and development , 1995 .

[3]  R. Heary,et al.  Persistent Iliac Crest Donor Site Pain: Independent Outcome Assessment , 2002, Neurosurgery.

[4]  C. Dickman,et al.  Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.

[5]  H. Chambers,et al.  Complications of iliac crest bone graft harvesting. , 1996, Clinical orthopaedics and related research.

[6]  Hak-Sun Kim,et al.  Simple Carrier Matrix Modifications Can Enhance Delivery of Recombinant Human Bone Morphogenetic Protein-2 for Posterolateral Spine Fusion , 2003, Spine.

[7]  T. Albert,et al.  Timing of surgical stabilization after cervical and thoracic trauma. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. , 2005, Journal of neurosurgery. Spine.

[8]  S. Ludwig,et al.  Osteoinductive bone graft substitutes for spinal fusion: a basic science summary. , 1999, The Orthopedic clinics of North America.

[9]  C. Branch,et al.  Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. , 2004, The spine journal : official journal of the North American Spine Society.

[10]  D. Polly,et al.  Computerized tomography evaluation of a resorbable implant after transforaminal lumbar interbody fusion. , 2004, Neurosurgical focus.

[11]  Safdar N. Khan,et al.  The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications , 2004, Expert opinion on biological therapy.

[12]  P. Mummaneni,et al.  Lumbar interbody fusion: state-of-the-art technical advances. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. , 2004, Journal of neurosurgery. Spine.

[13]  Banwart Jc,et al.  Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. , 1995 .

[14]  T. Murakami,et al.  Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. , 2003, Journal of biomedical materials research. Part A.

[15]  Adam J Starr,et al.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. , 2003, The Journal of bone and joint surgery. American volume.

[16]  E. Wang,et al.  Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[17]  F. Cui,et al.  Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits. , 2004, Chinese journal of traumatology = Zhonghua chuang shang za zhi.

[18]  N. Wright,et al.  In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. , 2001, Calcified tissue international.

[19]  J. Goulet,et al.  Autogenous Iliac Crest Bone Graft: Complications and Functional Assessment , 1997, Clinical orthopaedics and related research.

[20]  M. Marone,et al.  Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.

[21]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[22]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[23]  R. Balderston,et al.  Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2 , 2002, Spine.

[24]  V. Traynelis,et al.  A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. , 1998, Journal of neurosurgery.

[25]  K. Takaoka,et al.  Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2. , 1998, Bone.

[26]  J. Burkus,et al.  Radiographic Assessment of Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein Type 2 , 2003, Spine.

[27]  Koichiro Takahashi,et al.  Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. , 2003, Biomaterials.

[28]  S. Boden,et al.  Posterolateral Lumbar Intertransverse Process Spine Arthrodesis With Recombinant Human Bone Morphogenetic Protein 2/Hydroxyapatite‐Tricalcium Phosphate After Laminectomy in the Nonhuman Primate , 1999, Spine.

[29]  S. Boden,et al.  Experimental Posterolateral Lumbar Spinal Fusion With a Demineralized Bone Matrix Gel , 1998, Spine.

[30]  M. Chapman,et al.  Morbidity at bone graft donor sites. , 1989, Journal of orthopaedic trauma.

[31]  R. Delamarter,et al.  Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.

[32]  S. Stralka,et al.  A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. , 2003, Orthopedics.

[33]  N. Wright,et al.  In Vitro andIn Vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene , 2001, Calcified Tissue International.

[34]  H. Takita,et al.  Inhibition of BMP-Induced Ectopic Bone Formation by an Antiangiogenic Agent (Epigallocatechin 3-Gallate) , 2002, Connective tissue research.

[35]  J. Trotter.  Transmission of hepatitis C by implantation of a processed bone graft. A case report. , 2003, The Journal of bone and joint surgery. American volume.

[36]  T. Lanman,et al.  Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly(L-lactide-co-D,L-lactide) bioresorbable implants. , 2004, Neurosurgical focus.

[37]  村上 成道.  Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer , 2002 .

[38]  M. Urist,et al.  Bone Morphogenetic Protein , 1971, Journal of dental research.

[39]  J. Esterhai,et al.  Prognostic factors in nonunion of the tibia: an evaluation of 185 cases treated with constant direct current. , 1984, The Journal of trauma.

[40]  K. Lyons,et al.  Bone morphogenetic protein-2: biology and applications. , 1996, Clinical orthopaedics and related research.

[41]  S. Papapoulos,et al.  Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A. , 2002, Endocrinology.

[42]  H. Seeherman,et al.  A Review of Preclinical Program Development for Evaluating Injectable Carriers for Osteogenic Factors , 2003, The Journal of bone and joint surgery. American volume.

[43]  S. Boden,et al.  The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.

[44]  J. Michael Kabo,et al.  Histologic Evaluation of the Efficacy of rhBMP-2 Compared With Autograft Bone in Sheep Spinal Anterior Interbody Fusion , 2002, Spine.

[45]  A. Levine,et al.  Chronic Donor Site Pain Complicating Bone Graft Harvesting From the Posterior Iliac Crest for Spinal Fusion , 1992, Spine.

[46]  D. Polly,et al.  Economic Evaluation of Bone Morphogenetic Protein Versus Autogenous Iliac Crest Bone Graft in Single-Level Anterior Lumbar Fusion: An Evidence-Based Modeling Approach , 2002, Spine.

[47]  S. Boden,et al.  Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. , 1997, Journal of spinal disorders.

[48]  A. Valentin‐Opran,et al.  Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report. , 1999, Orthopedics.

[49]  N. Wright,et al.  Induction of Bone Formation Using a Recombinant Adenoviral Vector Carrying the Human BMP-2 Gene in a Rabbit Spinal Fusion Model , 1998, Calcified Tissue International.

[50]  Invasive Streptococcus pyogenes after allograft implantation--Colorado, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[51]  Marc A. Asher,et al.  Iliac Crest Bone Graft Harvest Donor Site Morbidity: A Statistical Evaluation , 1995, Spine.

[52]  A. Nordwall,et al.  2001 Volvo Award Winner in Clinical Studies: Lumbar Fusion Versus Nonsurgical Treatment for Chronic Low Back Pain: A Multicenter Randomized Controlled Trial From the Swedish Lumbar Spine Study Group , 2001, Spine.

[53]  J. Wozney,et al.  Clinical evaluation of recombinant human bone morphogenetic protein-2. , 2002, Clinical orthopaedics and related research.

[54]  J. Fischgrund,et al.  The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.

[55]  K. Miyazono.  Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. , 1999, Bone.

[56]  W. Hutton,et al.  Delivery of Recombinant Human Bone Morphogenetic Protein-2 Using a Compression-Resistant Matrix in Posterolateral Spine Fusion in the Rabbit and in the Non-Human Primate , 2002, Spine.

[57]  R. Müller,et al.  Exogenously regulated stem cell-mediated gene therapy for bone regeneration. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[58]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[59]  Robert Gunzburg,et al.  Use of a novel beta-tricalcium phosphate-based bone void filler as a graft extender in spinal fusion surgeries. , 2002, Orthopedics.

[60]  T. Zdeblick,et al.  Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion Device , 2003, Journal of spinal disorders & techniques.

[61]  F. Cui,et al.  Lumbar Spinal Fusion With a Mineralized Collagen Matrix and rhBMP-2 in a Rabbit Model , 2003, Spine.

[62]  T. Peppers,et al.  Use of an advanced formulation of beta-tricalcium phosphate as a bone extender in interbody lumbar fusion. , 2002, Orthopedics.

[63]  Z. Jaworski,et al.  Kinetics of osteoclasts and their nuclei in evolving secondary Haversian systems. , 1981, Journal of anatomy.

[64]  B. Summers,et al.  Donor site pain from the ilium. A complication of lumbar spine fusion. , 1989, The Journal of bone and joint surgery. British volume.

[65]  William A. Pierce,et al.  Effect of Recombinant Human Bone Morphogenetic Protein‐2 on Fracture Healing in a Goat Tibial Fracture Model , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  Safdar N. Khan,et al.  Recombinant Human Bone Morphogenetic Protein-2: Use in Spinal Fusion Applications , 2003, The Journal of bone and joint surgery. American volume.

[67]  J. Rodrigo,et al.  Contemporary Bone Graft Physiology and Surgery , 1985, Clinical orthopaedics and related research.

[68]  T. Kleeman,et al.  Laparoscopic Anterior Lumbar Interbody Fusion With rhBMP-2: A Prospective Study of Clinical and Radiographic Outcomes , 2001, Spine.

[69]  Jingyuan Fu,et al.  Signal Transduction of Bone Morphogenetic Proteins in Osteoblast Differentiation , 2003, The Journal of bone and joint surgery. American volume.

[70]  U. Walter,et al.  Signal transduction by cGMP in heart , 1991, Basic Research in Cardiology.

[71]  B. Summers,et al.  DONOR SITE PAIN FROM THE ILIUM , 1989 .

[72]  W. Hutton,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.

[73]  K. Johnson,et al.  Evaluation of recombinant human bone morphogenetic protein‐2 as a bone‐graft substitute in a canine segmental defect model , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[74]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[75]  Anders Nordwall,et al.  Chronic Low Back Pain and Fusion: A Comparison of Three Surgical Techniques: A Prospective Multicenter Randomized Study From the Swedish Lumbar Spine Study Group , 2002, Spine.

[76]  N. Colterjohn.  Procurement of Bone Graft from the Iliac Crest. An Operative Approach with Decreased Morbidity* , 1997, The Journal of bone and joint surgery. American volume.